Product How it works Pricing Blog FAQ About Contact
Tandem Diabetes Care

Tandem Diabetes Care (NASDAQ: TNDM) revenue

Tandem Diabetes Care reported revenue of $1,015m for fiscal 2025, 7.9% more than in fiscal 2024 ($940.2m). Since fiscal 2016 its revenue has grown by 1,104.5%, an average growth of 31.9% a year.

Tandem Diabetes Care has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2023, −6.7%.

Revenue, in millions of US dollars84.22016107.62017183.92018362.32019498.82020702.82021801.22022747.72023940.220241,0152025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$1,015m+7.9%−$187.3m−18.5%
2024$940.2m+25.7%−$99.1m−10.5%
2023$747.7m−6.7%−$233.2m−31.2%
2022$801.2m+14.0%−$92.8m−11.6%
2021$702.8m+40.9%$22.7m3.2%
2020$498.8m+37.7%−$8.0m−1.6%
2019$362.3m+97.0%−$16.7m−4.6%
2018$183.9m+70.9%−$44.6m−24.3%
2017$107.6m+27.7%−$62.9m−58.5%
2016$84.2m—−$78.1m−92.6%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Tandem Diabetes Care revenue compared with its sector

By revenue for its latest fiscal year, Tandem Diabetes Care ranks 148th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Tandem Diabetes Care, 7.9%.

RankCompanyRevenueRevenue growth
146thEmbecta$1,080m−3.8%
147thAcadia Pharmaceuticals$1,072m11.9%
148thTandem Diabetes Care$1,015m7.9%
149thInnovAge$989.7m15.9%
150thGuardant Health$982.0m32.9%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Tandem Diabetes Care

How much revenue did Tandem Diabetes Care make in fiscal 2025?
Tandem Diabetes Care reported revenue of $1,015m for fiscal 2025, compared with $940.2m in fiscal 2024.
How much has the revenue of Tandem Diabetes Care grown?
Between fiscal 2016 and fiscal 2025 it went from $84.2m to $1,015m: 1,104.5% more, an average growth of 31.9% a year.
What was the best year for revenue at Tandem Diabetes Care?
Of its last 10 fiscal years, fiscal 2025, with $1,015m.
Where does Tandem Diabetes Care rank in its sector by revenue?
It ranks 148th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Tandem Diabetes Care come from?
From the annual report (Form 10-K) that Tandem Diabetes Care files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Tandem Diabetes Care files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Tandem Diabetes Care: the Tandem Diabetes Care page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.